Recent advances in research on thyroid carcinogenesis have yielded applications of diagnostic molecular biomarkers and profiling panels in the management of thyroid nodules. The specific utility of these novel, clinically available molecular tests is becoming widely appreciated, especially in perioperative decision making by the surgeon regarding the need for surgery and the extent of initial resection.


Continue Reading

A task force was convened by the Surgical Affairs Committee of the American Thyroid Association and was charged with writing this article.

READ FULL ARTICLE Curated publisher From Liebertpub